Therapeutics News
-
Australian startup develops nasal spray technology for mental health disorders
Therapeutics | News | 0 Comment | 30 Jul, 2021
A nasal spray technology that enables the delivery of psychedelic and non-psychedelic drugs to treat mental health disor...Read more
-
Australia advocates cognitive behavioural therapy for perinatal care
Therapeutics | News | 0 Comment | 29 Jul, 2021
New research from Monash University has found that a non-drug sleep program, using Cognitive Behavioural Therapy (CBT), ...Read more
-
China develops novel 'bacterial gene markers' test for early detection of colon cancer
Therapeutics | News | 0 Comment | 29 Jul, 2021
The faecal immunochemical test (FIT) is commonly used to screen for colorectal cancer but it has low sensitivity (around...Read more
-
‘Hard-to-drug targets have become our prime focus’
Therapeutics | Opinion | By Hithaishi C Bhaksar | 0 Comment | 29 Jul, 2021
Hummingbird Bioscience, an innovative clinical-stage biotech company with its APAC headquarter in Singapore, is focused ...Read more
-
Gilead Sciences launches Asia Pacific ALL4LIVER Grant 2021 with focus on hepatitis B
Therapeutics | News | 0 Comment | 28 Jul, 2021
American biopharma firm Gilead Sciences, Inc. has announced the launch of the 2021 Gilead Asia Pacific ALL4LIVER Grant, ...Read more
-
Industry-academia partnership in South Korea for non-alcoholic steatohepatitis treatment
Therapeutics | News | 0 Comment | 28 Jul, 2021
Deargen, an artificial intelligence (AI)-powered drug discovery and development startup, has signed an agreement with So...Read more
-
Singapore, US assess risk of vascular inflammation for diabetes patients
Therapeutics | News | 0 Comment | 28 Jul, 2021
A team of international scientists from Nanyang Technological University, Singapore (NTU Singapore), Tan Tock Seng Hospi...Read more
-
Japan uses quantum physics to destroy cancer cells
Therapeutics | News | 0 Comment | 27 Jul, 2021
Scientists at Japan-based Kyoto University’s Institute for Integrated Cell-Material Sciences (iCeMS) and colleague...Read more
-
China uncovers neurodegeneration mechanism of Alzheimer’s
Therapeutics | News | 0 Comment | 27 Jul, 2021
Alzheimer’s Disease (AD), the most common type of dementia, causes the death of neurons and leads to shrinking of ...Read more
-
Therapeutics | Opinion | 0 Comment | 23 Jul, 2021
In an email interaction with BioSpectrum, EpimAb’s Founder and CEO, Dr Chengbin Wu tells us more about the company...Read more
-
Australia examines use of hemp extracts to treat anxiety, seizures
Therapeutics | News | 0 Comment | 23 Jul, 2021
Pharmacologists at the University of Sydney in Australia have found tantalising clues as to why low-dose CBD products co...Read more
-
Korean firm Celltrion developing solution to treat COVID-19 patients at home
Therapeutics | News | 0 Comment | 23 Jul, 2021
Inhalon Biopharma, Inc., a US-based clinical-stage immunotherapy company developing an inhaled "muco-trapping" anti...Read more
-
Novigenix wins 2021 Felix Burda award in Medicine & Science
Therapeutics | News | 0 Comment | 22 Jul, 2021
Novigenix SA, a leading Swiss biotech that develops and commercializes Immuno-Transcriptomic precision oncology solution...Read more
-
NZ lays focus on combined screening of stomach and bowel cancer
Therapeutics | News | 0 Comment | 22 Jul, 2021
Dr Stephen Inns and his team from the University of Otago, in New Zealand (NZ) have secured almost $250,000 from the Hea...Read more
-
Quest for permanent correction of underlying genetic defect continues
Therapeutics | Opinion | By Ayesha Siddiqui | 0 Comment | 21 Jul, 2021
After years of research, the field of gene therapies is at a tipping point. Recent years have seen immense progress in t...Read more
-
Terumo Europe and UMCU ink MoU to develop solutions in interventional oncology
Therapeutics | News | 0 Comment | 21 Jul, 2021
Terumo Europe and University Medical Center Utrecht (UMC Utrecht) have announced that they signed a Memorandum of Unders...Read more
-
Taiwan links antihypertensive drug usage with lower risk of dementia
Therapeutics | News | 0 Comment | 20 Jul, 2021
According to a recent study done by researchers in Taiwan, angiotensin receptor blockers (ARBs) may have protective effe...Read more
-
Therapeutics | Opinion | By Devin Partida is a medical and health tech writer from San Francisco, California. She also writes about medical technologies, AI and cybersecurity on ReHack.com. | 0 Comment | 20 Jul, 2021
Millennials Have Elevated Risks for Some Obesity-Related Cancers The American Cancer Society led a study that l...Read more
